Demonstration of the Venture Medical Sacral Dressing Kit

Sep 1, 2022
Demonstration of the Venture Medical Sacral Dressing Kit

Get a first-hand look at the application process of the Venture Medical Sacral Dressing Kit in this short video. We illustrate the kit's key role in protecting wounds from contaminants for patients with pressure ulcers who also suffer from incontinence. The demonstration also highlights how this kit supports the performance of advanced treatments such as CTPs. Learn to enhance your wound care practices and promote better wound healing with this cutting-edge solution.

Get a first-hand look at the application process of the Venture Medical Sacral Dressing Kit in this short video. We illustrate the kit's key role in protecting wounds from contaminants for patients with pressure ulcers who also suffer from incontinence. The demonstration also highlights how this kit supports the performance of advanced treatments such as CTPs. Learn to enhance your wound care practices and promote better wound healing with this cutting-edge solution.

More News & Updates

Stay Up-To-Date With
Venture Medical

Mar 11, 2025

Open Wound Research and Venture Medical Announce Collaboration to Advance Pressure Ulcer Research

Feb 12, 2025

Innovation & Adaptability: An Interview with the CEO of Venture Medical,LLC

In an industry where innovation and adaptability are key, Venture Medical, LLC has carved out a unique space, blending bold ambition with a steadfast commitment to quality and service. Over the past few years, the company has experienced exponential growth, but what truly sets Venture apart isn’t just its expansion—it’s the culture, leadership philosophy, and relentless pursuit of excellence that fuel its success.

Jan 15, 2025

The LCD Is Frozen, Now What?

On Monday during his first day in office, President Trump signed an Executive Order (EO) freezing the pending LCD policy that would limit access to skin substitutes for chronic wound care. To be clear - this is a policy freeze pending further action.

Jan 1, 2025

The Scrutiny on Skin Substitutes: Shifting The Focus From Medicare Advantage

While the top six major insurance companies have reported soaring profits—some rising by thousands of percentage points since the Medicare Advantage program was enacted, many patients enrolled in Medicare Advantage plans claim they didn’t even realize they were leaving traditional Medicare. This lack of transparency raises important questions about how these plans are marketed and the tactics used to encourage patients to switch.

Oct 28, 2024

Venture Medical announced as the exclusive US distributor of Vendaje AC ®

Venture Medical, LLC has been announced as the exclusive distributor of Vendaje AC®, a wound care product manufactured by BioStem Technologies Inc. (OTC: BSEM).

Oct 21, 2024

The Rising Costs of Wound Care: Finding Solutions Without Sacrificing Access

Under a system previously reliant solely on hospital outpatient departments, many patients—especially the elderly in care facilities, the poor, the homebound, the rural, and the otherwise disenfranchised—never enjoyed equitable access. Today, however, more patients than ever are receiving wound care as providers are motivated to bring advanced modalities directly to them.

Jan 24, 2024

MicroGen Diagnostics in Chronic Wounds

“Explore the fascinating realm of microbiology and healthcare in the MicroGenDX Mic’d Up podcast, hosted by Rick Martin, CEO of MicroGenDX. Join Rick and his special guest, the esteemed Caroline Fife, MD, FAAFP, CWS, Professor of Medicine at Baylor College of Medicine

Dec 14, 2023

Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions

The national ASP publication of AmnioWrap2™ knocks down barriers that will provide healthcare professionals and their patients with the opportunity to use AmnioWrap2™, a superior wound care product for certain applications.

Sep 7, 2022

The Gap Between Clinical Trials and Real-World Chronic Wound Patients

Caroline Fife, M.D. highlights a concerning discrepancy between the characteristics of patients with chronic wounds in real-world settings and those selected for clinical trials.